increasing patient access to targeted therapies through patient and provider education
Increase global patient access to targeted therapies through customized education solutions that bridge the gaps in trial and testing awareness for providers, patients, and caregivers.
We are passionate about increasing clinical trial enrollment to accelerate drug development. We provide pathologists and other healthcare professionals with the tools they need to navigate the evolving landscape of cancer diagnosis and treatment.
A webinar series designed to help pathologists learn best practices in testing for TRK, RET, MET, and other emerging mutations in a wide range of tumor histologies
Tumors with NTRK Fusions in Head and Neck Pathology
Presented By Alena Skalova
Approaches to TRK, RET, MET and other Emerging Mutations in Lung Cancer Pathology
Presented By Patrick Pauwels
Why Work With Us?
Celerity was built to solve specific rare patient target bottlenecks
We are not a PR firm, we understand clinical trials and specifically rare patient clinical trials
We have a large network of pathologists in 16 countries with a five year history of working together on TRK, RET, ROS1 and other rare disease trials
We are the only services company that works from the pathologist to the patient/caregiver to enroll more patients in your trials
We balance large pharma compliance with the need for hustle in small biotechs
For any inquiries, questions or commendations, please call: 303-531-1667 or fill out the following form
300 Center Drive
Superior, CO 80026